For this reason, alternative analytes (e.g., CRP, IL-6, soluble urokinase plasminogen receptors) have been tested for their ability to better assess the inflammatory burden in patients affected by HF [45,46]. The gene discussed is CRP; the disease is hydrops fetalis.